Association of tumor necrosis factor genetic polymorphism with chronic atrophic gastritis and gastric adenocarcinoma in Chinese Han population. by Fei, BY et al.
PO Box 2345, Beijing 100023, China                                                                                                                                                               World J Gastroenterol  2004;10(9):1256-1261
Fax: +86-10-85381893                                                                                                                                                                                                                                 World Journal of Gastroenterology
E-mail: wjg@wjgnet.com     www.wjgnet.com                                                                                                                                   Copyright © 2004 by The WJG Press ISSN 1007-9327
• GASTRIC CANCER •
Association of tumor necrosis factor genetic polymorphism with
chronic atrophic gastritis and gastric adenocarcinoma in Chinese
Han population
Bao-Ying Fei, Bing Xia, Chang-Sheng Deng, Xiao-Qing Xia, Min Xie, J Bart A Crusius, A Salvador Pena
Bao-Ying Fei, Department of Gastroenterology, Zhejiang Provincial
People’s Hospital, Hangzhou 310014, Zhejiang Province, China
Bing Xia, Chang-Sheng Deng, Department of Gastroenterology,
Wuhan University Zhongnan Hospital, Wuhan 430071, Hubei
Province, China
Xiao-Qing Xia, Min Xie, Department of Tumor Surgery, Hubei
Provincial Tumor Hospital, Wuhan 430071, Hubei Province, China
J Bart A Crusius, A Salvador Pena, Laboratory of GI immunogenetics
Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Supported by a grant from provincial public health bureau, Hubei
Province, No. 97420
Correspondence to: Dr Bao-Ying Fei, Department of Gastroenterology,
Zhejiang Provincial People’s Hospital, Hanzhou 310014, Zhejiang
Province, China.  feibaoying6924@tom.com
Telephone: +86-571-85239988    Fax: +86-571-85131448
Received: 2003-11-18    Accepted: 2003-12-16
Abstract
AIM: To investigate the association of TNF polymorphisms
with chronic atrophic gastritis (CAG) and gastric adenocarcin-
oma in Chinese Han patients.
METHODS: The TNFa-e 5 microsatellites and 3 RFLP sites
were typed using PCR technique, followed by high-voltage
denaturing PAGE with silver staining and restriction enzyme
digestion respectively in specimens from 53 patients with
CAG and 56 patients with gastric adenocarcinoma and
164 healthy controls. The PCR products were cloned and
sequenced.
RESULTS: The frequency of TNF-b Ncol*1/2 genotype was
higher in patients with chronic atrophic gastritis than in
healthy controls, but no significant difference was observed
(60.38% vs 46.34%, P=0.076). The frequency of TNa10
allele was significantly higher in patients with chronic
atrophic gastritis than in healthy controls (19.81% vs 11.89%,
P=0.04). However, it did not relate to age, gender, atrophic
degree or intestinal metaplasia in patients with chronic
atrophic gastritis. The frequency of TNF-b Ncol*1/2 and
d2/d6 genotypes were significantly higher in patients with
gastric adenocarcinoma  than in healthy individuals(P>0.05).
However, TNF-b Ncol*1/2 and d2/d6 genotypes did not relate
to age, gender, grade of differentiation and clinicopathologic
stage in patients with gastric adenocarcinoma. The frequency
of TNFa6b5c1 haplotype homozygote was significantly
lower in patients with gastric adenocarcinoma than in
healthy controls (1.79% vs 15.85%, P=0.006).
CONCLUSION: TNFa10 allele may be a risk factor for chronic
atrophic gastritis. TNF-b Ncol*1/2 and d2/d6 genotypes are
associated with the susceptibility to gastric adenocarcinoma,
whereas TNFa6b5c1 haplotype homozygote may contribute
to the resistance against gastric adenocarcinoma.
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INTRODUCTION
Gastric adenocarcinoma is one of the most frequent malignant
diseases in the world, but the causes of gastric cancer remains
unclear. The crude mortality rate of stomach cancer in China
was 25.2 per 105 (32.8 per 105 for males and 17.0 per 105 for
females), which comprised 23.2% of the total death of cancer
from 1990 to 1992, making stomach cancer the leading cause of
the death among cancers[1].
     Tumor necrosis factor (TNF) is a multifunctional cytokine
and its anti-tumor effect has attracted particular attention. TNF
was found at a higher concentration in patients with malignant
tumor. Forones et al.[2] reported increased TNF-a expression
in the sera of patients with advanced gastric cancer. TNF-a
mRNA was markedly increased in gastric carcinoma tissue[3].
Recombinant TNF has been demonstrated to have considerable
treatment effect on gastric cancer in vitro[4,5].
       The gene for TNF-a and lymphotoxin-a (TNF-b), referred
to as the TNF locus, are tandemly arranged within a 7-kilobase
region in the HLA on the short arm of chromosome 6. HLA has
recently been found to contribute to cancer development[6-9].
Several RFLP sites and 5 microsatellites within the TNF gene
have been identified. Some studies have shown that TNF
individual alleles were correlated to secretion from activated
monocytes[10-13]. Furthermore, some experiments found that TNF
secretion was also associated with TNF haplotypes, not only
individual alleles[14]. These findings suggest that TNF
polymorphisms may play a role in the pathogenesis of several
autoimmune, infectious and neoplastic diseases.
     Chronic atrophic gastritis (CAG) is believed to be the
precancerous lesion of gastric adenocarcinoma. In the present
study, we examined whether TNF genetic polymorphisms were
associated with CAG and gastric adenocarcinoma in Chinese
Han population. Additionally, we determined whether the
associations between TNF genetic polymorphisms and CAG
and gastric adenocarcinoma varied with clinicopathologic
features of the 2 diseases.
MATERIALS AND METHODS
Patients and genomic DNA extraction
The subjects of this study included 56 patients with
gastric adenocarcinoma (43 males, 13 females; mean age
55.6±12.2 years), 53 patients with CAG (32 males, 21 females;
mean age 53.5±11.4 years), and 164 unrelated healthy
individuals (113 males, 51 females; mean age 52.5±11.3 years)
from Chinese Han population in Hubei province of China. The
diagnoses of gastric adenocarcinoma and CAG were confirmed
by histopathology examinations. Genomic DNA was extracted
from venous blood by a salting out procedure with minor
modifications.
TNF polymorphism typing
Five microsatellites were amplified using a single step PCR reaction
with primers described by Pociot et al.[15]. TNF microsatellite
alleles were typed by a 60 g/L polyacrylamide, 0.4-mm sequencing
gel, followed by silver nitrate staining. Fragments were sized
using DNA markers and simultaneously typed with known alleles
derived from the cloned PGEM-T vector.
      The sites in the first intron of TNF-b marked by AspH1 and
Nco1 were analyzed using PCR and endonuclease digestion.
BSIHKA1, an isoschizomer of AspH1 (New England Biolabs,
Beverley, MA) was used instead of AspH1. The digested
products were electrophoresed in 1 g/L ethidium bromide-
stained 15 g/L agarose gels. Similarly, the TNF-308 polymorphism
was examined by PCR amplification and Nco1 digestion. The
digested products were separated on a 100 g/L non-denaturing
polyacrylamide gel. Alleles were visualized as described for
TNF microsatellite typing.
Cloning and sequencing
The PCR products of 5 microsatellites were purified and ligated
with PGEM-T vector. High efficiency JM 109 competent cells
were used in the process of transformation. Needed transformants
were obtained by blue/white color screening and standard
ampicillin selection. Recombinant plasmid DNA were isolated
and identified. Sequencing was done on ABI 377 DNA sequencer.
Statistical analysis
Allele frequencies in patients and control groups were
calculated by direct counting. The Chi-square test and Fisher’s
exact test were used for statistical analysis. Hardy-Weiberg
equilibrium was tested in a 2×n analysis using Chi-Square.
RESULTS
The frequencies of the various alleles at 8 TNF polymorphic
sites in 3 groups are shown in Table 1. The frequency of TNFa10
allele was significantly higher in patients with CAG than in
healthy controls (19.81% vs 11.89%, P=0.04, OR=1.83, 95%CI
Table 1  Distribution frequency of TNF alleles at 8 polymorphic loci in CAG, gastric adenocarcinoma and healthy controls
TNF locus Allele Size (bp) Controls (n=164) CAG (n=53) Gastric adenocarcinoma (n=56)     P
TNFa    a1      97         0.0183      0.0094                                           0.0089
   a2      99         0.1583     0.1698         0.2054
   a3    101         0.0000     0.0094         0.0268
   a4    103         0.0061     0.0094         0.0178
   a5    105         0.0396      0.0378         0.0089
   a6    107         0.3811      0.3585         0.3928
   a7    109         0.0793     0.0378         0.0536
   a8    111         0.0061     0.0094         0.0000
   a9    113         0.0335     0.0566         0.0152
 a10    115         0.1189     0.1981*         0.1161 0.040
 a11    117         0.0945     0.0660         0.0803
 a12    119         0.0091     0.0000         0.0000
 a13    121         0.0549      0.0378         0.0152
TNFb    b1    125         0.1006      0.0755         0.1339
   b2    126         0.0000     0.0000         0.0000
   b3    127         0.1128     0.0943         0.0536
   b4    128         0.3293     0.3585         0.3482
   b5    129         0.4512     0.4717         0.4643
   b6    130         0.0000     0.0000         0.0000
   b7    131         0.0061     0.0000         0.0000
TNFc    c1    159         0.2104     0.7264         0.7679
   c2    161         0.7896     0.2736         0.2321
TNFd   d1    124         0.0061     0.0094         0.0000
  d2    126         0.0548     0.0755         0.0536
  d3    128         0.0457     0.0566         0.0446
  d4    130         0.3537     0.3774                      0.3393
  d5    132         0.1341     0.1226         0.1786
  d6    134         0.3018     0.2925                      0.2857
  d7    136         0.0000     0.0000         0.0000
  d8    138         0.1037     0.0660         0.0982
TNFe   e1      99         0.0640     0.0755         0.0000
  e3    103         0.8110     0.8302         0.7768
  e4    105         0.1159     0.0660         0.1250
TNF-a 308     1         0.9329     0.9434         0.9732
    2         0.0671     0.0566         0.0268
TNF-b Nco1     1         0.4817     0.4528         0.4464
    2         0.5183     0.5472         0.5536
TNF-b AspH1     1         0.3079     0.3302         0.3571
    2         0.6921     0.6698         0.6429
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1.02-3.27). However, it was not related to age, gender, atrophic
degree and intestinal metaplasia in patients with CAG (Table 2).
The frequency of TNF-b Ncol*1/2 genotype was higher in
patients with chronic atrophic gastritis than in healthy controls
(Table 3). However no significant difference was observed
(60.38% vs 46.34%,  P=0.076).
    The frequency of TNF-b Ncol*1/2 genotype was significantly
higher in patients with gastric adenocarcinoma than in healthy
controls (64.29% vs 46.34%, P=0.020, OR=2.08, 95%CI 1. 12-3.86).
The frequency of d2/d6 genotype was also significantly higher
in patients with gastric adenocarcinoma than in healthy
individuals (10.71% vs 2.44%, P=0.028, OR=4.8, 95%CI  1.18-19.47).
However, TNF-b Ncol*1/2 and d2/d6 genotypes were not related
to age, gender, grade of differentiation and clinicopathologic
stage in patients with gastric adenocarcinoma (Table 4).
       Based on maximum likelihood estimate, 4 most frequent 3-
locus haplotypes have been described in 4 European
populations: TNFa11b4c1, TNFa2b1c2, TNFa6b5c1, TNFa10b4c1.
These haplotypes have also been observed in our study. By
analysis of 2 locus association, we established 5 extended
haplotypes which integrated alleles across the TNF locus in
our population: TNFa6b5c1d8e4TNF308-1TNF b Nco1-
1TNFAspH1-2, TNFa2b1c2d5e1TNF308-1TNF b Nco1-
2TNFAspH1-2, TNFa11b4c1d4e3TNF308-1TNF b Nco1-
2TNFAspH1-1, TNFa10b4c1d4e3TNF308-1TNF b Nco1-
2TNFAspH1-1, TNFa2b3c1d2e3TNF308-2TNFAspH1-2. There
were no significant differences in haplotype frequencies
between CAG, gastric adenocarcinoma, and control groups for
these haplotypes. However the frequency of TNFa6b5c1
haplotype homozygote was  significantly lower in patients with
gastric adenocarcinoma than in healthy individuals (1.79% vs
15.85%, P=0.006). It was not related to age, gender, grade of
differentiation and clinicopathologic stage in patients with
gastric adenocarcinoma.
Figure 1  Nucleotide sequence of  the cloned PGEM-T vector comprising TNFa6 allele (135 241) and TNFb5 allele  (29 157), 150 179
fragment is 15 (AC/GT) repeats, 107 127 fragment is 10.5 (TC/GA) repeats.
Figure 2  Nucleotide sequence of the cloned PGEM-T vector comprising TNFc1 allele (35 193), 59 76 fragment is 9 (TC/GA) repeats.
1258                  ISSN 1007-9327      CN 14-1219/ R      World J Gastroenterol    May 1, 2004   Volume 10   Number 9
Figure 3  Nucleotide sequence of the cloned PGEM-T vector comprising TNFd4 allele (34 163), 64 85 fragment is 11 (TC/GA) repeats.
Figure 4  Nucleotide sequence of the cloned PGEM-T vector comprising TNFe3 allele (29 131), 47 62 fragment is 8 (TC/GA) repeats.
Table 2  Association between TNFa10 allele and clinical features of CAG
Groups Age Gender Atrophic degree            Intestinal metaplasia
 (yr)        M      F Mild        Moderate       Severe        Positive           Negative
TNFa10+           53.9±9.6       13       8    3 12            6 14       7
TNFa10-           53.2±12.5       19    13    6 18            8 22    10
Table 3  Distribution frequency of TNF TNF-b Ncol*1/2 and TNFd2/d6 genotypes in CAG, gastric adenocarcinoma and healthy controls
Group                                 TNF-b Ncol*1/2 TNFd2/d6
            +      - +               -
Controls          76               88             4           160
CAG                                   32    21             2             51
Gastric adenocarcinoma                       36a              20                                                       6c            50
aP<0.05 vs compared with control group of TNF-b Ncol*1/2, cP<0.05 vs compared with control group of TNFd2/d6.
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Table 4  Association between d2/d6 and TNF-b Ncol*1/2 genotypes and clinical features of gastric adenocarcinoma
Group Age Gender Grade of differentiation         Clinicopathologic stage
(yr)       M                   F High and moderate               Low I-II                III-IV
d2/d6+         59.7±9.5         5                   1                                  0                                   6                        4                       2
d2/d6-         55.1±12.5       38                 12                                13                                 37                      21                     29
1/2+         56.7±12.2       26                 10                                  9                                 27                      15                     21
1/2-         53.6±11.5       17                   3                                  4                                 16                      10                     10
     The sequences of five TNF microsatellites (Figures 1-4)
were consistent with that from a GeneBank database. However,
several base exchanges were noted as following: TNFa at
position 218 T G, TNFc at 129 G C, 170 A G, TNFd at 87 G
A, 91 A G, and TNFe at 81 C T.
DISCUSSION
Genetic predisposition appears to be important in the
pathogenesis of gastric adenocarcinoma. Genetic factors
determining cancer risk have been postulated for the last
decades and seem to be more apparent for gastric
adenocarcinoma[16-21]. The relevant genes mediating the risk of
gastric adenocarcinoma have not been identified until now.
Progress of CAG towards gastric adenocarcinoma seems to be
influenced by genetic factors[22,23].
       A diallelic TNF-b polymorphism detected using the enzyme
Ncol influences the TNF-a and/or -b secretion of peripheral
blood mononuclear cells[24]. Park et al.[25] found that TNF-b
Ncol*1/1 genotypes showed an increased risk for colorectal
cancer, and that TNF-b*1 allele played some role in the initial
step of tumorigenesis or activation of dormant tumor cells,
whereas TNF-b*2 allele mediated some functions associated
with cytotoxicity of tumor cells. Our result showed that the
frequency of TNF-b Ncol*1/2 genotype was significantly higher
in patients with gastric adenocarcinoma than in healthy
individuals. It suggested that TNF-b Ncol*1/2 genotype was
related to the pathogenesis of gastric cancer. At the same time
we found the frequency of TNF-b Ncol*1/2 genotype was also
high in patients with CAG. However, the association between
TNF-b Ncol*1/2 genotype and CAG did not show a significant
difference. Further studies are necessary to elucidate If TNF-b
Ncol*1/2 genotype is a risk factor for CAG. The frequency of
d2/d6 genotype was also significantly higher in patients with
gastric adenocarcinoma than in healthy individuals. It indicated
that d2/d6 genotype might have some effect on pathogenesis
of gastric adenocarcinoma.
    Azuma et al.[23] reported that the DQA1*0102 might
contribute to resistance against H pylori associated gastric
atrophy and immunogenetic factors were important in the
etiology of H pylori associated gastric atrophy. Proinflammatory
IL-1beta polymorphisms are associated with hypochlorhydria
and atrophic gastritis in Japan[24]. The presence of the IL-1*C
allele may also indicate a risk of mucosal atrophy of the stomach
in the Japanese population[26]. Our study has shown an
association between TNFa10 allele and CAG, but not between
TNFa10 allele and gastric adenocarcinoma. It suggested that
TNFa10 allele might be a host risk factor for CAG. However, it
was not related to age, gender, atrophic degree and intestinal
metaplasia in patients with CAG.
      A significant reduction in high expressing haplotypes was
found in patients with follicular lymphoma[27]. Hajeer et al.[28]
reported the TNF a2-b4-d5 haplotype was significantly
associated with the number of basal cell carcinoma (BCC)
lesions. It provides the evidence that TNF microsatellite
haplotype may influence the pathogenesis of multiple BCC.
We found negative association between TNFa6b5c1 haplotype
homozygote and gastric adenocarcinoma. The frequency of
TNFa6b5c1 haplotype homozygote was lower in patients with
gastric adenocarcinoma. It suggested that TNFa6b5c1
haplotype homozygote might contribute to the resistance
against gastric adenocarcinoma. The absence of TNFa6b5c1
haplotype homozygote might increase the risk of gastric
adenocarcinoma.
       The TNF-a 308A allele has been associated with enhanced
TNF-a expression[10]. Machado et al. proposed that individuals
carrying TNF-a 308A allele had an increased risk for gastric
cancer with an OR of 1.9[29]. However our results showed that
there was no association between TNF-a 308 allele and gastric
adenocarcinoma. Similarly, Wu et al. reported no association
was noted between gastric cancer and controls in the
distribution of TNF-a genotypes in Taiwanese Chinese
population[30]. The discrepancy may be attributable to ethnic
difference.
     Onishi et al.[31] demonstrated a significantly favorable
prognosis in the renal carcinoma patients with TNF-b1/1
homozygote compared with other zygotes of TNF-beta
polymorphism. The patients with TNF-b1/1 homozygote
showed much lower stage and/or grade than those of other
zygotes. TNF polymorphisms TNF+488A and TNF-859T were
associated with grade of tumour in patients with bladder cancer[32].
However, in our study TNF-b Ncol*1/2 and d2/d6 genotypes
and TNFa6b5c1 haplotype were not related to age, gender,
grade of differentiation and clinicopathologic stage in patients
with gastric adenocarcinoma. Patients with d2/d6 genotype
were present with a lowly differentiated tumor, however the
difference did not reach statistical significance. Larger sample
studies are needed.
      The association between TNF genetic polymorphisms and
CAG and gastric adenocarcinoma is not clear. However, 2 distinct
potential mechanisms can be proposed. First, TNF alleles may
be involved in genetically controlled variations in TNF production
as previously described. Another possible explanation is that
these genes are not responsible for the pathophysiological
mechanisms but are linked closely to other responsible genes.
TNF has been reported to be in linkage disequilibrium with
HLA genes[33-35]. The negative association of TNFa3-e1 with
rheumatoid arthritis may be secondary to the negative linkage
disequilibrium between TNFa3-e1 and HLA-DR4[36]. Additional
studies will be necessary to investigate whether TNF genes are
independent of other linked genes to play a role.
     With regard to several base exchanges in our sequencing
result, more studies should be done to verify whether they are
caused by ethnic difference or other factors.
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